Novartis shares jump on breast cancer drug trials success

Norge Nyheter Nyheter

Novartis shares jump on breast cancer drug trials success
Norge Siste Nytt,Norge Overskrifter
  • 📰 FoxBusiness
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 53%

Novartis said the drug showed positive topline results from an interim analysis of NATALEE in a broad population of patients with early breast cancer.

In a company statement, Novartis said the drug exhibited positive topline results from an interim analysis of NATALEE, a Phase III trial evaluating Kisqali, in a broad population of patients with early breast cancer.

According to the statement, the Independent Data Monitoring Committee recommended stopping the trial early because the primary endpoint of invasive disease-free survival had been met. Signage is displayed on the exterior of the Novartis AG Institutes for BioMedical Research building in Cambridge, Mass.

Dr. Dennis Slamon, Director of Clinical and Translational Research at the University of California, and NATALEE trial lead investigator, said "While most patients are diagnosed and treated early with the aim to cure breast cancer, the risk of cancer returning, often as metastatic disease, peaks within three years after diagnosis, but never goes away completely.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

FoxBusiness /  🏆 458. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Novartis gets positive result from breast-cancer drug trialNovartis gets positive result from breast-cancer drug trialThe Phase 3 trial, named Natalee, was stopped early as the primary endpoint has been met, Novartis said.
Les mer »

Novartis buoyed by trial success in early-stage breast cancerNovartis buoyed by trial success in early-stage breast cancerNovartis's Kisqali breast cancer drug cut the risk of recurrence in women who were diagnosed at an early stage of the disease in a pivotal trial, providing a confidence boost for the drugmaker's growth prospects.
Les mer »

First Citizens shares leap on SVB deal as Novartis stock boosted by breast-cancer drug trialFirst Citizens shares leap on SVB deal as Novartis stock boosted by breast-cancer drug trialHere are some of the most active stocks in premarket trade, as U.S. stock index futures were boosted on improving news from the banking sector.
Les mer »

Southern Utahns share tips for making money on unwanted itemsSouthern Utahns share tips for making money on unwanted itemsSpring cleaning can be cathartic – more space, less clutter. But a lot of stuff that needs to go costs good money, making it hard to just give away. That's where retail sales of home items come in.
Les mer »

LIB's Zack and Irina Share When They Knew Their Engagement Was a ‘Mistake’LIB's Zack and Irina Share When They Knew Their Engagement Was a ‘Mistake’Zack Goytowski proposed to Irina Solomonova on ‘Love Is Blind’ season 4 before they split one week later — exclusive interview
Les mer »

City leaders to share Final Four security plans ahead of events this weekendCity leaders to share Final Four security plans ahead of events this weekendEven if you're not going to the games, there are plenty of other things surrounding the Final Four that you'll want to know about, including street closures.
Les mer »



Render Time: 2025-03-06 20:39:14